Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.norrispharma.com | |
Market Cap | 12.67 Cr. | |
Enterprise Value(EV) | 34.46 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.91 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -13.73 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -0.92 | Calculated using Price: 12.67 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,700 Shares |
FaceValue | 10 | |
About Norris Medicines Ltd. | ||
The business area of the company is manufacturing of Injections and Medicinal formulations. |
1 Day |
|
-1.93% |
1 Week |
|
-9.37% |
1 Month |
|
+3.01% |
3 Month |
|
-41.80% |
6 Month |
|
+8.48% |
1 Year |
|
-2.16% |
2 Year |
|
-63.75% |
5 Year |
|
+111.17% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -17.93 | 0.71 | -15.52 | -76.01 | -138.44 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | 3.99 | 4.06 | -4.06 | -17.04 | -9.18 | -18.63 | -17.87 | -6.59 | 3.17 | |
Return on Assets (%) | -5.8 | 0.23 | -4.18 | -13.07 | -9.37 | -16.48 | -29.19 | -21.99 | -13.88 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 2 | 0 | -2 | -7 | -11 | -12 | -14 | |
Non Curr. Liab. | 6 | 6 | 6 | 5 | 8 | 11 | 13 | 16 | 17 | 19 | |
Curr. Liab. | 5 | 5 | 10 | 11 | 9 | 8 | 12 | 7 | 8 | 8 | |
Minority Int. | |||||||||||
Equity & Liab. | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 13 | 13 | |
Non Curr. Assets | 10 | 10 | 11 | 11 | 10 | 9 | 9 | 8 | 8 | 8 | |
Curr. Assets | 7 | 7 | 9 | 8 | 7 | 7 | 8 | 4 | 5 | 5 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 13 | 13 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 19 | 19 | 20 | 14 | 16 | 8 | 12 | 9 | 8 | 5 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 19 | 19 | 21 | 14 | 16 | 8 | 12 | 9 | 8 | 5 | |
Total Expenditure | -17 | -18 | -21 | -15 | -17 | -10 | -14 | -10 | -7 | -5 | |
PBIDT | 2 | 1 | 0 | -2 | -1 | -2 | -2 | 0 | 1 | 0 | |
Interest | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -2 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | -1 | 0 | 0 | 1 | 0 | 1 | -1 | -1 | -1 | -1 | |
Exceptional Items | |||||||||||
PAT | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | -2 | |
Adjusted EPS | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | -2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 1 | 1 | -1 | 1 | -2 | -3 | 1 | -1 | 1 | |
Cash Fr. Inv. | -2 | -1 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Finan. | 0 | 0 | -1 | 3 | -1 | 2 | 3 | -1 | 1 | -1 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 24 Apr 2024
Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As per attachment. |
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 As per attachment. |
Fri, 29 Mar 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 29-04-2024 Outcome of Board Meeting held on 29-04-2024 |
Thu, 25 Apr 2024 |
Opening at High |
Opening at Low |
Opening at High for 3 days |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |